OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA
Macao
J/006735
Filed on 2022-12-23
J/006735
Filed on 2022-12-23
GENE THERAPY CONSTRUCTS FOR THE TREATMENT OF PROPIONIC ACIDEMIA CAUSED BY MUTATIONS IN PROPIONYL-COA CARBOXYLASE ALPHA
Patent Cooperation Treaty
PCT/US2022/082527
Filed on 2022-12-29
PCT/US2022/082527
Filed on 2022-12-29
GENE THERAPY FOR COMBINED METHYLMALONIC ACIDEMIA/ACIDURIA AND HYPERHOMOCYSTEINEMIA/HOMOCYSTINURIA, COBALAMIN C TYPE, AND DEFICIENCY OF MMACHC
US Application 18/056,356
Filed on 2022-11-17
Filed on 2022-11-17
ABERRANT POST-TRANSLATIONAL MODIFICATIONS(PTMS) IN METHYL- AND PROPIONIC ACIDEMIA AND A MUTANT SIRTUIN (SIRT) TO METABOLIZE PTMS
US Application 17/923,394
Filed on 2022-11-04
Filed on 2022-11-04
SYNTHETIC GENES FOR THE TREATMENT OF PROPIONIC ACIDEMIA CAUSED BY MUTATIONS IN PROPIONYL-COA CARBOXYLASE BETA
US Application 17/766,067
Filed on 2022-04-01
Filed on 2022-04-01
SYNTHETIC GENES FOR THE TREATMENT OF PROPIONIC ACIDEMIA CAUSED BY MUTATIONS IN PROPIONYL-COA CARBOXYLASE BETA
European Patent
20804709.2
Filed on 2022-04-26
20804709.2
Filed on 2022-04-26
OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA
Japan
2022-000125
Filed on 2022-01-04
2022-000125
Filed on 2022-01-04
CANCER DETECTION AND CLASSIFICATION
US Application 17/632,783
Filed on 2022-02-03
Filed on 2022-02-03
NON-DISRUPTIVE GENE THERAPY FOR THE TREATMENT OF MMA
Hong Kong
62021044683.2
Filed on 2021-12-16
62021044683.2
Filed on 2021-12-16
NON-DISRUPTIVE GENE THERAPY FOR THE TREATMENT OF MMA
Hong Kong
62021042143.9
Filed on 2021-11-09
62021042143.9
Filed on 2021-11-09